Eric E Morgan
Overview
Explore the profile of Eric E Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kattapuram N, Shadman S, Morgan E, Benton C, Awojoodu S, Kim D, et al.
JACC Cardiovasc Imaging
. 2024 Oct;
18(1):125-127.
PMID: 39453353
No abstract available.
2.
Ma K, Mitchell T, Dougher M, Sharon C, Tortorello G, Elder D, et al.
Clin Cancer Res
. 2024 Sep;
30(21):4987-4994.
PMID: 39248505
Purpose: Neoadjuvant anti-PD-1 therapy in melanoma may increase tumor-infiltrating lymphocytes (TIL), and more TIL are associated with better treatment response. A major pathologic response (MPR) in melanoma after neoadjuvant anti-PD-1...
3.
Kattapuram N, Shadman S, Morgan E, Benton C, Awojoodu S, Kim D, et al.
medRxiv
. 2024 Feb;
PMID: 38410488
Background: Regadenoson is used to induce hyperemia in cardiac imaging, facilitating diagnosis of ischemia and assessment of coronary flow reserve (CFR). While the regadenoson package insert recommends administration of radionuclide...
4.
Murphy C, Wang K, Wachuku C, Prasad A, Dhawan I, Morgan E, et al.
SAGE Open Med Case Rep
. 2024 Feb;
12:2050313X241231515.
PMID: 38404499
This case describes an atypical cutaneous presentation of metastatic gastric carcinoma in a patient initially presenting with dysphagia and a sclerotic red plaque overlying the anterior neck and chest. Skin...
5.
Dasi A, Kring D, Selvaraj B, Morgan P, Gerity C, Morgan E, et al.
Pediatr Radiol
. 2023 Oct;
53(13):2622-2632.
PMID: 37837456
Background: Ferumoxytol is becoming more widely used as an off-label blood-pool contrast agent for MR angiography (MRA) and four-dimensional (4D) flow imaging in pediatric cardiovascular disease. Brand and generic versions...
6.
Banbury S, Rauck C, Morgan E, Arisi M, Berk-Krauss J, Buckey T, et al.
JAAD Case Rep
. 2023 Sep;
39:78-80.
PMID: 37664446
No abstract available.
7.
Haynes D, Morgan E, Chu E
Hum Pathol
. 2023 May;
140:129-143.
PMID: 37146945
Targeted cancer treatments-designed to interfere with specific molecular signals responsible for tumor survival and progression-have shown benefit over conventional chemotherapies but may lead to diverse cutaneous adverse effects. This review...
8.
Dube P, Khalaf F, DeRiso A, Mohammed C, Connolly J, Battepati D, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140402
Paraoxonase-1 (PON-1) is a hydrolytic enzyme associated with HDL, contributing to its anti-inflammatory, antioxidant, and anti-atherogenic properties. Deficiencies in PON-1 activity result in oxidative stress and detrimental clinical outcomes in...
9.
Morgan E, Morran M, Horen N, Weaver D, Nestor-Kalinoski A
Physiol Genomics
. 2021 Nov;
53(12):534-545.
PMID: 34755572
Increased arterial stiffness is an independent risk factor for hypertension, stroke, and cardiovascular morbidity. Thus, understanding the factors contributing to vascular stiffness is of critical importance. Here, we used a...
10.
Roy S, Edwards J, Tomcho J, Schreckenberger Z, Bearss N, Zhang Y, et al.
Function (Oxf)
. 2020 Dec;
2(1):zqaa029.
PMID: 33363281
Exercise capacity is a strong predictor of all-cause morbidity and mortality in humans. However, the associated hemodynamic traits that link this valuable indicator to its subsequent disease risks are numerable....